Stay updated on Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.

Latest updates to the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedNew revision entry v3.3.3 was added to the history; the HHS Vulnerability Disclosure link and prior revision v3.3.2 entry were removed. These changes do not affect the study details or records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLatest version shows the study status updated to Terminated and notes that the research center conducted a more comprehensive study. It also adds new sections (Contacts/Locations, Study Design, Study Status, Study Identification, Recruitment Status) and removes the previous 'Recruiting' status along with the location 'Institute of Hematology & Blood Diseases Hospital, China'.SummaryDifference2%

- Check40 days agoChange DetectedFooter now displays Revision: v3.3.2, replacing Revision: v3.2.0; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check47 days agoChange DetectedRemoved the general notice about government funding and NIH operating status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check61 days agoChange DetectedThe record history shows only the earliest version with no recorded changes. The screenshots appear identical, indicating no updates to core content.SummaryDifference0.1%

- Check90 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference13%

Stay in the know with updates to Venetoclax Regimen to Prevent AML Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Regimen to Prevent AML Relapse Clinical Trial page.